139 related articles for article (PubMed ID: 16095491)
21. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease.
Takenaka M; Tiriveedhi V; Subramanian V; Hoshinaga K; Patterson AG; Mohanakumar T
PLoS One; 2012; 7(8):e42370. PubMed ID: 22900015
[TBL] [Abstract][Full Text] [Related]
23. Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats.
Ikonen TS; Brazelton TR; Berry GJ; Shorthouse RS; Morris RE
Transplantation; 2000 Sep; 70(6):857-63. PubMed ID: 11014638
[TBL] [Abstract][Full Text] [Related]
24. Trachea allograft class I molecules directly activate and retain CD8+ T cells that cause obliterative airways disease.
Richards DM; Dalheimer SL; Hertz MI; Mueller DL
J Immunol; 2003 Dec; 171(12):6919-28. PubMed ID: 14662899
[TBL] [Abstract][Full Text] [Related]
25. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
Krebs R; Tikkanen JM; Ropponen JO; Jeltsch M; Jokinen JJ; Ylä-Herttuala S; Nykänen AI; Lemström KB
Am J Pathol; 2012 Nov; 181(5):1607-20. PubMed ID: 22959907
[TBL] [Abstract][Full Text] [Related]
26. Tissue inhibitor of metalloproteinase-1 deficiency abrogates obliterative airway disease after heterotopic tracheal transplantation.
Chen P; Farivar AS; Mulligan MS; Madtes DK
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):464-72. PubMed ID: 16388023
[TBL] [Abstract][Full Text] [Related]
27. PG490-88, a derivative of triptolide, attenuates obliterative airway disease in a mouse heterotopic tracheal allograft model.
Leonard CT; Soccal PM; Berry GJ; Doyle RL; Theodore J; Duncan SR; Rosen GD
J Heart Lung Transplant; 2002 Dec; 21(12):1314-8. PubMed ID: 12490278
[TBL] [Abstract][Full Text] [Related]
28. Clopidogrel reduces post-transplant obliterative bronchiolitis.
Preidl RH; Eckl S; Ramsperger-Gleixner M; Koch N; Spriewald BM; Weyand M; Ensminger SM
Transpl Int; 2013 Oct; 26(10):1038-48. PubMed ID: 23952051
[TBL] [Abstract][Full Text] [Related]
29. Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation.
Matsuda Y; Wang X; Oishi H; Guan Z; Saito M; Liu M; Keshavjee S; Chow CW
Am J Transplant; 2016 Jan; 16(1):342-52. PubMed ID: 26308240
[TBL] [Abstract][Full Text] [Related]
30. Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation.
Angaswamy N; Saini D; Ramachandran S; Nath DS; Phelan D; Hachem R; Trulock E; Patterson GA; Mohanakumar T
Hum Immunol; 2010 Jun; 71(6):560-5. PubMed ID: 20211214
[TBL] [Abstract][Full Text] [Related]
31. Prolonged inhibition of obliterative airway disease in murine tracheal allografts by brief treatment with anti-leukocyte function-associated antigen-1 (CD11a) monoclonal antibody.
Morikawa M; Brazelton TR; Berry GJ; Morris RE
Transplantation; 2001 Jun; 71(11):1616-21. PubMed ID: 11435974
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling in murine obliterative airway disease.
Lande JD; Dalheimer SL; Mueller DL; Hertz MI; King RA
Am J Transplant; 2005 Sep; 5(9):2170-84. PubMed ID: 16095496
[TBL] [Abstract][Full Text] [Related]
33. Suppression of the obliteration process by ventilation in a mouse orthotopic tracheal transplantation model.
Chen C; Zhang YZ; Zheng H; Xu BB; Gao W
Transplantation; 2009 Jun; 87(12):1762-8. PubMed ID: 19543051
[TBL] [Abstract][Full Text] [Related]
34. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
35. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts.
Koskinen PK; Kallio EA; Krebs R; Lemström KB
Am J Respir Crit Care Med; 1997 Jan; 155(1):303-12. PubMed ID: 9001329
[TBL] [Abstract][Full Text] [Related]
36. Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse.
Ropponen JO; Keränen MA; Raissadati A; Nykänen AI; Krebs R; Lemström KB; Tikkanen JM
J Heart Lung Transplant; 2016 May; 35(5):671-8. PubMed ID: 26856676
[TBL] [Abstract][Full Text] [Related]
37. Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome.
Jaramillo A; Naziruddin B; Zhang L; Reznik SI; Smith MA; Aloush AA; Trulock EP; Patterson GA; Mohanakumar T
Transplantation; 2001 Apr; 71(7):966-76. PubMed ID: 11349733
[TBL] [Abstract][Full Text] [Related]
38. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation.
Jaramillo A; Smith MA; Phelan D; Sundaresan S; Trulock EP; Lynch JP; Cooper JD; Patterson GA; Mohanakumar T
Transplantation; 1999 Apr; 67(8):1155-61. PubMed ID: 10232567
[TBL] [Abstract][Full Text] [Related]
39. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways.
Hertz MI; Jessurun J; King MB; Savik SK; Murray JJ
Am J Pathol; 1993 Jun; 142(6):1945-51. PubMed ID: 8506960
[TBL] [Abstract][Full Text] [Related]
40. Immune cells in a mouse airway model of obliterative bronchiolitis.
Neuringer IP; Mannon RB; Coffman TM; Parsons M; Burns K; Yankaskas JR; Aris RM
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):379-86. PubMed ID: 9730865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
